Overview
The August 25th scan identified 313 total 20-week breakout signals, split into 195 bullish (62.3%) and 118 bearish (37.7%) moves. This places the market in a Balanced-to-Mildly-Bullish zone — institutions are net accumulators, but the SA Regime reading of Cautious tempers enthusiasm. Breadth sits at 55.8% above SMA-40 with Bullish/Neutral sentiment, suggesting participation is broadening but not yet euphoric.
Sector leadership is rotating defensively: Health Care and Communication Services top the ATR% rankings (3.4% each), while Technology, Industrials, and Utilities are contracting (-1.0% to -2.0%). This divergence signals capital rotating away from rate-sensitive growth names toward defensive-growth hybrids.
Quality Score: 3/5. With a Cautious regime overlay, only setups combining strong ATR expansion, real institutional sponsorship, and sector alignment qualify for higher conviction. Several top dollar-movers today are leveraged ETPs with negligible institutional ownership (0–1 funds), diluting the pool of true institutional-grade breakouts. Selectivity is warranted.
Top 5 Bullish Picks
SUJA ($9.33) — Food/Beverage, Non-Alcoholic
Weekly Momentum: SUJA posted a 20%+ percentage breakout on 1.4x relative volume (741,824 vs. 525,800 avg), a modest but confirmed volume expansion. ADR% of 12.1% and LOD Risk ATR% of 60.7% indicate elevated intraday volatility — traders should size accordingly.
| Level | Price |
|---|---|
| Current | $9.33 |
| Risk (Stop) | $8.00 |
| Target | $11.11 |
| ATR | $0.89 |
Institutional Interest: 42 funds hold positions (54.3% of float) — the strongest institutional footprint among today’s bullish leaders, lending credibility to this breakout.
MF ($17.86) — Software, Enterprise Specialty
Weekly Momentum: MF’s percentage breakout came on light volume (0.1x relative, 82,881 vs. 1.29M avg), a caution flag despite the strong 21.9% ADR%. The 742.5% gain off 52-week lows shows a dramatic base-building recovery, though thin volume tempers conviction near term.
| Level | Price |
|---|---|
| Current | $17.86 |
| Risk (Stop) | $14.07 |
| Target | $22.92 |
| ATR | $2.53 |
Institutional Interest: No institutional funds currently reported — this is a retail-driven move requiring confirmation before scaling in.
VOGX ($31.53) — Medical, Development Biotech
Weekly Momentum: VOGX rallied on a 143.5% gain from 52-week lows and sits just 9.9% off its 52-week high — a strong technical position. Volume was below average (0.4x), suggesting the move is early-stage and could accelerate on a volume catalyst.
| Level | Price |
|---|---|
| Current | $31.53 |
| Risk (Stop) | $25.37 |
| Target | $39.75 |
| ATR | $4.11 |
Institutional Interest: 0 funds reported. Bucket classification: bucket_0_youth_ipo_less_5yrs, marking this as a recent IPO — higher risk/reward profile typical of young biotech names.
SCTX ($31.20) — Medical, Development Biotech
Weekly Momentum: SCTX confirmed its breakout with 1.2x relative volume and an 80.3% gain from 52-week lows, now just 21.2% off highs. The combination of moderate ADR% (14.7%) and controlled LOD Risk ATR% (11.2%) suggests a cleaner, less volatile setup than peers.
| Level | Price |
|---|---|
| Current | $31.20 |
| Risk (Stop) | $25.17 |
| Target | $39.24 |
| ATR | $4.02 |
Institutional Interest: No institutional ownership yet reported; this remains a speculative biotech breakout best suited for smaller position sizing.
BRNX ($5.56) — Energy, Alternative/Other
Weekly Momentum: BRNX surged on 2.8x relative volume (1,578,689 vs. 571,840 avg), confirming genuine buying interest. Despite being 98.9% off its 52-week high, the 169.7% recovery from lows signals a potential bottoming reversal in the alternative energy space.
| Level | Price |
|---|---|
| Current | $5.56 |
| Risk (Stop) | $4.35 |
| Target | $7.18 |
| ATR | $0.81 |
Institutional Interest: 1 fund holds a 0.3% stake — minimal but present sponsorship in an otherwise speculative name.
Bearish Alerts
Five names flagged bearish breakdowns, led by WNTR (-3.68 ATR multiple) and AADX (-2.57 ATR multiple, 113 institutional funds) — the latter notable for its heavy institutional base, implying distribution rather than retail panic. FNG (-1.82 ATR) and CBRX (-1.13 ATR) are both ETF/ETN products with 0 institutional holders, consistent with structured-product volatility rather than fundamental deterioration. CNXU, a development biotech, broke down on 2.2x relative volume with no institutional support, a high-risk setup to avoid.
Weakness is concentrated in Finance-ETF/ETN and pockets of Aerospace/Defense and Medical Development Biotech — the same biotech corner producing bullish signals today, underscoring binary risk in that space.
Sector Theme
Cross-sector data confirms a defensive rotation: Health Care and Communication Services lead ATR% expansion while Technology, Industrials, and Utilities contract. Today’s bullish breakout list reflects this tilt, with Medical/Biotech names (VOGX, SCTX) and Food/Beverage (SUJA) showing genuine strength, while Technology-adjacent Software (MF) shows momentum but lacks volume confirmation. ETF/ETN leveraged products dominate the dollar-move category but carry minimal institutional backing, functioning more as trading vehicles than conviction signals.
Institutional Summary
SUJA leads institutional accumulation among bullish picks with 42 funds (54.3% of float), the clearest institutional-grade signal today. On the bearish side, AADX‘s 113-fund base breaking down is the most consequential distribution signal, warranting close monitoring. BRNX shows nascent institutional interest (1 fund, 0.3%), while MF, VOGX, and SCTX remain purely retail/momentum-driven with zero institutional footprints — appropriate for smaller, higher-risk allocations only.